<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200222046573N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-07</date_registration>
      <primary_sponsor>Bu Ali Sina University</primary_sponsor>
      <public_title>The effect of kinesio taping on dynamic knee valgus</public_title>
      <acronym></acronym>
      <scientific_title>The effect of kinesio taping on control of posture ،kinematic and knee joint proprioception in physically active female with dynamic knee valgus</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46050</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization was done by lottery in which the participant choose one of two papers ("intervention" and "placebo control"), Blinding description: Patients will not know in which group will they be placed because in both groups the kinesiotape will be glued to the same area of ​​the thigh and leg and in both groups, the size of the attached tape was the same .the only difference between the two group was that in the  kinesiotape  group  was  taped  by  the  Kinesiotape with tension, while the placebo group  was  taped  with  Kinesiotape  but  with-out any tension and patients did not notic any difference  in kinesiotaping tension.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Dynamic Knee Valgus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: kinesio taping group (kinesio tape with yellow color  ATEX brand made in South Korea) will be applied to the muscles of the gluteus medius with %20 tension and tibialis anterior with %50 tension for 48 hours, then kinematic, control of posture and knee joint properioception   will be measured before and after application of kinesio taping. Intervention 2: Control Placebo group": control placebo group with kinesiotape (kinesio tape with yellow color  ATEX brand made in South Korea) intervention  as the first intervention group but without tension will be applied to the muscles of the gluteus medius and tibialis anterior for 48 hours, then kinematic, control of posture and knee joint properioception  will be measured before and after application of kinesio taping.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Need more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hosnieh Roomiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan15</address>
        <city>Roomeshgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6845154453</zip>
        <telephone>+98 66 3266 2428</telephone>
        <email>hosnieh1373@gmail.com</email>
        <affiliation>Bu Ali sina university</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hosnieh Roomiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan15</address>
        <city>Roomeshgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6845154453</zip>
        <telephone>+98 66 3266 2428</telephone>
        <email>hosnieh1373@gmail.com</email>
        <affiliation>Bu Ali sina university</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>age range 18 to 28 years
Having a knee dynamic valgus angle of more than 12 degrees
Having at least two years of regular sports experience</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>28 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of mechanical back pain in the last year
History of any damage in the last six months
History of knee surgery
History of ankle surgery.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: kinesio taping group (kinesio tape with yellow color  ATEX brand made in South Korea) will be applied to the muscles of the gluteus medius with %20 tension and tibialis anterior with %50 tension for 48 hours, then kinematic, control of posture and knee joint properioception   will be measured before and after application of kinesio taping.</i_keyword>
      <i_keyword>Control Placebo group": control placebo group with kinesiotape (kinesio tape with yellow color  ATEX brand made in South Korea) intervention  as the first intervention group but without tension will be applied to the muscles of the gluteus medius and tibialis anterior for 48 hours, then kinematic, control of posture and knee joint properioception  will be measured before and after application of kinesio taping.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Disorder in kinematic. Timepoint: Before the intervention begins and 48 hours after the end of the intervention. Method of measurement: Kinovea software.</prim_outcome>
      <prim_outcome>Disorder in control of posture. Timepoint: Before the intervention begins and 48 hours after the end of the intervention. Method of measurement: Y balance test and Bess balance test.</prim_outcome>
      <prim_outcome>Disorder in  knee joint properioception. Timepoint: Before the intervention begins and 48 hours after the end of the intervention. Method of measurement: goniameter.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Knee flexion and valgus angles. Timepoint: Before the intervention begins and 48 hours  after the end of the intervention. Method of measurement: kinovea software.</sec_outcome>
      <sec_outcome>Balance scores. Timepoint: Before the intervention begins and 48 hours  after the end of the intervention. Method of measurement: Y balance test and Bess balance test.</sec_outcome>
      <sec_outcome>Joint angle reconstruction error. Timepoint: Before the intervention begins and 48 hours  after the end of the intervention. Method of measurement: goniameter.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Bu Ali Sina University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-13</approval_date>
        <contact_name>Ethics committee of Hamedan University of Medical Sciences</contact_name>
        <contact_address>Bu Ali Sina University, Abu Taleb St, Modares Quarter, Hamedan Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
